INVITRO STUDIES OF WATER ACTIVITY AND BACTERIAL-GROWTH INHIBITION OF SUCROSE POLYETHYLENE GLYCOL-400-HYDROGEN PEROXIDE AND XYLOSE POLYETHYLENE GLYCOL-400-HYDROGEN PEROXIDE PASTES USED TO TREAT INFECTED WOUNDS

被引:11
作者
AMBROSE, U
MIDDLETON, K
SEAL, D
机构
[1] NORTHWICK PK HOSP & CLIN RES CTR,DEPT PHARM,WATFORD RD,HARROW HA1 3UJ,MIDDX,ENGLAND
[2] NORTHWICK PK HOSP & CLIN RES CTR,DEPT MICROBIOL,HARROW HA1 3UJ,MIDDX,ENGLAND
关键词
D O I
10.1128/AAC.35.9.1799
中图分类号
Q93 [微生物学];
学科分类号
071005 [微生物学]; 100705 [微生物与生化药学];
摘要
Water activity and bacterial growth inhibition have been studied in formulations comprising either sucrose or xylose along with polyethylene glycol 400 and hydrogen peroxide. The pastes are chemically stable for 6 months if stored at 2 to 8-degrees-C and have been shown to lower water activity to levels below those essential for bacterial growth and to be bactericidal even when diluted up to 50% with serum. Of the organisms tested, Staphylococcus aureus proved the least susceptible to the bactericidal effects of these pastes, and candida and gram-negative organisms proved the most susceptible. Pastes without hydrogen peroxide were less rapidly bactericidal than pastes with hydrogen peroxide, while polyethylene glycol 400 itself was found to have considerable antimicrobial activity. It is suggested that sucrose paste may be of benefit as a treatment for infected and malodorous wounds.
引用
收藏
页码:1799 / 1803
页数:5
相关论文
共 9 条
[1]
ARCHER HG, 1990, J EXP PATHOL, V71, P155
[2]
INVITRO STUDY OF BACTERIAL-GROWTH INHIBITION IN CONCENTRATED SUGAR SOLUTIONS - MICROBIOLOGICAL BASIS FOR THE USE OF SUGAR IN TREATING INFECTED WOUNDS [J].
CHIRIFE, J ;
HERSZAGE, L ;
JOSEPH, A ;
KOHN, ES .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 23 (05) :766-773
[3]
CHIRIFE J, 1982, LANCET, V1, P560
[4]
INVITRO ANTI-BACTERIAL ACTIVITY OF CONCENTRATED POLYETHYLENE GLYCOL-400 SOLUTIONS [J].
CHIRIFE, J ;
HERSZAGE, L ;
JOSEPH, A ;
BOZZINI, JP ;
LEARDINI, N ;
KOHN, ES .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1983, 24 (03) :409-412
[5]
GARRATT DC, 1964, QUANTITATIVE ANAL DR, P328
[6]
GORDON H, 1985, LANCET, V2, P663
[7]
MIDDLETON KR, 1985, PHARM J, V235, P757
[8]
TROUILLET JL, 1985, LANCET, V2, P180
[9]
WILSON CG, 1984, PHARM INT, V5, P94